X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14449) 14449
Publication (502) 502
Book Review (235) 235
Book / eBook (183) 183
Newspaper Article (138) 138
Magazine Article (100) 100
Newsletter (46) 46
Book Chapter (29) 29
Conference Proceeding (12) 12
Government Document (9) 9
Reference (9) 9
Dissertation (8) 8
Paper (2) 2
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10938) 10938
male (5933) 5933
atherosclerosis (4954) 4954
female (4825) 4825
arteriosclerosis (4491) 4491
middle aged (4319) 4319
animals (3999) 3999
arteriosclerosis - drug therapy (3701) 3701
aged (3579) 3579
index medicus (2899) 2899
adult (2598) 2598
risk factors (2468) 2468
arteriosclerosis - etiology (1704) 1704
arteriosclerosis - prevention & control (1578) 1578
cardiac & cardiovascular systems (1518) 1518
cholesterol (1501) 1501
cardiovascular diseases (1449) 1449
inflammation (1449) 1449
cardiovascular disease (1403) 1403
peripheral vascular disease (1356) 1356
arteriosclerosis - complications (1259) 1259
arteriosclerosis - pathology (1180) 1180
rabbits (1105) 1105
cholesterol - blood (1099) 1099
arteriosclerosis - physiopathology (1076) 1076
mice (1049) 1049
arteriosclerosis - blood (1045) 1045
hypertension (1044) 1044
medicine (987) 987
lipids (976) 976
diabetes (943) 943
lipoproteins (924) 924
disease (878) 878
risk (840) 840
lipids - blood (828) 828
multidisciplinary sciences (816) 816
arteriosclerosis - metabolism (806) 806
heart diseases (770) 770
diabetes mellitus (767) 767
research article (750) 750
pharmacology & pharmacy (744) 744
patients (739) 739
blood pressure (727) 727
mortality (725) 725
stroke (722) 722
research (719) 719
proteins (703) 703
cardiology (702) 702
time factors (692) 692
medicine, general & internal (689) 689
science (686) 686
clinical trials as topic (684) 684
treatment outcome (678) 678
hypertension - drug therapy (663) 663
rats (656) 656
low-density-lipoprotein (651) 651
myocardial-infarction (642) 642
oxidative stress (637) 637
arteriosclerosis - therapy (636) 636
analysis (634) 634
disease models, animal (630) 630
cardiovascular-disease (629) 629
metabolism (614) 614
health aspects (605) 605
coronary artery disease (587) 587
surgery (585) 585
drug therapy (576) 576
intracranial arteriosclerosis - drug therapy (565) 565
follow-up studies (556) 556
studies (547) 547
triglycerides - blood (547) 547
rodents (546) 546
coronary vessels (544) 544
aorta (543) 543
care and treatment (543) 543
macrophages (539) 539
medical research (539) 539
endothelium (530) 530
aged, 80 and over (529) 529
prevention (528) 528
therapy (525) 525
medicine & public health (523) 523
expression (517) 517
heart (513) 513
endocrinology & metabolism (512) 512
medicine, research & experimental (507) 507
coronary heart disease (493) 493
cell biology (492) 492
hypertension - complications (489) 489
c-reactive protein (486) 486
lipid metabolism (480) 480
statins (480) 480
thrombosis (480) 480
health risk assessment (478) 478
arteriosclerosis obliterans - drug therapy (474) 474
health risks (474) 474
ischemia (474) 474
arteries (473) 473
biochemistry & molecular biology (473) 473
hematology (470) 470
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (136) 136
Collection Dvlpm't (Acquisitions) - Vendor file (13) 13
Collection Dvlpm't (Acquisitions) - Closed Orders (8) 8
UofT at Mississauga - Stacks (8) 8
Online Resources - Online (4) 4
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Scarborough Hospital - General (2) 2
UTL at Downsview - May be requested (2) 2
Baycrest Hospital - Stacks (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Course Reserves (1) 1
Law (Bora Laskin) - Stacks (1) 1
OISE - Stacks (1) 1
Robarts - Stacks (1) 1
Toronto East General Hospital - Online (1) 1
UofT at Scarborough - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11772) 11772
German (685) 685
Russian (678) 678
Italian (525) 525
French (347) 347
Japanese (258) 258
Polish (169) 169
Spanish (130) 130
Chinese (92) 92
Portuguese (47) 47
Czech (37) 37
Dutch (31) 31
Hungarian (31) 31
Romanian (31) 31
Swedish (30) 30
Danish (28) 28
Finnish (20) 20
Norwegian (18) 18
Ukrainian (17) 17
Bulgarian (9) 9
Hebrew (7) 7
Serbian (6) 6
Slovak (6) 6
Turkish (5) 5
Croatian (4) 4
Lithuanian (3) 3
Arabic (2) 2
Afrikaans (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 04/2007, Volume 115, Issue 14, pp. 1948 - 1967
Despite compliance with lifestyle recommendations, some children and adolescents with high-risk hyperlipidemia will require lipid-lowering drug therapy,... 
Drugs | Pediatrics | Lipids | Hypercholesterolemia | AHA Scientific Statements | FACTOR INTERVENTION PROJECT | INTIMA-MEDIA THICKNESS | DEPENDENT DIABETES-MELLITUS | lipids | CARDIAC & CARDIOVASCULAR SYSTEMS | LOW-CHOLESTEROL DIET | drugs | LOW-DENSITY-LIPOPROTEIN | RESTORES ENDOTHELIAL FUNCTION | BODY-FAT DISTRIBUTION | hypercholesterolemia | BLOOD-PRESSURE | pediatrics | HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA | PERIPHERAL VASCULAR DISEASE | LOW-SATURATED-FAT | Dyslipidemias - complications | Humans | Hyperlipoproteinemias - epidemiology | Middle Aged | Child, Preschool | Male | Arteriosclerosis - epidemiology | Phytotherapy | Child | Dyslipidemias - diagnosis | Metabolic Syndrome - epidemiology | Arteriosclerosis - etiology | HIV Protease Inhibitors - adverse effects | Hypolipidemic Agents - adverse effects | Arteriosclerosis - diagnostic imaging | Risk Factors | Combined Modality Therapy | Disease Progression | Arteriosclerosis - prevention & control | Diet, Fat-Restricted | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Hyperlipoproteinemia Type II - diet therapy | Adolescent | Age of Onset | HIV Infections - complications | Hypolipidemic Agents - therapeutic use | Arteriosclerosis - pathology | Cholesterol, Dietary | Dyslipidemias - diet therapy | Hyperlipoproteinemias - classification | Age Factors | Hyperlipoproteinemia Type II - diagnosis | Infant | Exercise Therapy | Contraindications | Dietary Fats | Hyperlipoproteinemias - drug therapy | Ultrasonography | Diabetes Complications - epidemiology | Adult | Cholesterol, LDL - blood | Female | Anticholesteremic Agents - classification | Hyperlipoproteinemia Type II - drug therapy | Hyperlipoproteinemia Type II - complications | Dyslipidemias - drug therapy | Clinical Trials as Topic | Anticholesteremic Agents - therapeutic use | Hyperlipoproteinemia Type II - epidemiology | Obesity - epidemiology | Hypolipidemic Agents - administration & dosage | HIV Infections - drug therapy | Hyperlipoproteinemias - genetics | Care and treatment | Demographic aspects | Hyperlipidemia | Research | Drug therapy | Risk factors
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 12, pp. 1119 - 1131
Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The... 
C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2017, Volume 70, Issue 18, pp. 2278 - 2289
Journal Article